Managing Anaemia in IBD

Similar documents
Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations

Northern Treatment Advisory Group

IRON DEFICIENCY / ANAEMIA ANTHONY BEETON

Trust Guideline for the Management and Administration of Intravenous Iron in Adults under the Gastroenterology Directorate

CAUTION: You must refer to the intranet for the most recent version of this procedural document.

Αναιμία και ΙΦΝΕ. Ιωάννης Ε. Κουτρουμπάκης Αναπληρωτής Καθηγητής Γαστρεντερολογίας Ιατρικής Σχολής Πανεπιστημίου Κρήτης

Policy for the use of intravenous Iron Dextran (CosmoFer )

Oral Iron Safe, Effective, and Misunderstood Duke Debates 2017

Anaemia in the ICU: Is there an alternative to using blood transfusion?

YEAR III Pharm.D Dr. V. Chitra

GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE

27/01/2019. Anaemia, Transfusion and TACO Lise Estcourt. Anaemia. What is anaemia?

Intravenous Iron: A Good Thing Made Better? Marilyn Telen, MD Wellcome Professor of Medicine Duke University

INTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharmaceuticals

Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease

Anemia Management in Peritoneal Dialysis Patients Pranay Kathuria, FACP, FASN

BONE MARROW PERIPHERAL BLOOD Erythrocyte

A WHITER SHADE OF PALE MANAGING PERIOPERATIVE ANAEMIA

Drugs Used in Anemia

ferric carboxymaltose 50mg iron/ml solution for injection/infusion (Ferinject ) SMC No. (463/08) Vifor Pharma UK Ltd

Advanced Level. Understanding Iron Deficiency Anaemia in Chronic Kidney Disease Information at Advanced Level. Karen Jenkins RN, PGDip HE, MSc

Iron metabolism anemia and beyond. Jacek Lange Perm, 8 October 2016

RENAL ANAEMIA. South West Renal Training Scheme Cardiff October 2018

Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease Nielsen, Ole Haagen; Ainsworth, Mark; Coskun, Mehmet; Weiss, Günter

Intravenous ferric carboxymaltose:

Dr Charlie Baker Consultant Anaesthetist UHNM. Being a place our f amilies would choose

Serum soluble transferrin receptor in hypochromic microcytic anaemia

iron III isomaltoside 1000 (contains 50mg iron per ml) (Diafer ), solution for injection SMC No. (1177/16) Pharmacosmos UK Limited

Preoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD

3/22/2017. Ironing Out the Details: A Review of Iron Deficiency Anemia and Safety Update for Iron Replacement Products. Disclosure.

Anaemia and iron deficiency in children with inflammatory bowel disease

Efficacy and safety of high dose accelerated intravenous iron sucrose in patients of iron deficiency anemia

Hematopoiesis, The hematopoietic machinery requires a constant supply iron, vitamin B 12, and folic acid.

Classification of Anaemia

NUTRITIONAL CARE IN ANEMIA

ANEMIA IN CANCER ROLE OF IV IRON

Ferric carboxymaltose (Ferinject) for iron-deficiency anaemia

Managing peri-operative anaemiathe Papworth way. Dr Andrew A Klein Royal Papworth Hospital Cambridge UK

B12 and Iron Supplementation

Rama Nada. -Ensherah Mokheemer. 1 P a g e

Intravenous (IV) iron

Beaumont Hospital Department of Transplantation, Urology and Nephrology. Guideline for administering Intravenous Ferinject in the Renal Unit

Nutritional Requirements for Inflammatory Bowel Disease. Dale Lee, MD, MSCE Assistant Professor of Pediatrics University of Washington

DETECTION, INVESTIGATION AND MANAGEMENT OF ANAEMIA

Iron Therapy. Dr Kiran Desai Consultant In Gastroenterology Walsall Manor Hospital

A Systemic Review of Iron Deficiency Anemia in Adults and the Clinical Management of Diagnosis and Treatment

This document is to help guide the use of the provided GRH IV Iron Sucrose package. The documents included in the IV Iron Sucrose Package are:

Jens Frederik Dahlerup a, Bent A. Jacobsen b, Janneke van der Woude c, Lars-Åke Bark d, Lars L. Thomsen e and Stefan Lindgren f.

Iron depletion in frequently donating whole blood donors. B. Mayer, H. Radtke

Emerging Evidence On Anemia

Iron deficiency anemia:

CosmoFer. Dose Selection and Calculation Guide for intravenous administration. Low molecular weight iron dextran. Revised TDI tables

Public Assessment Report Scientific discussion. Monofer 100 mg/ml solution for injection/infusion (iron(iii) isomaltoside 1000) SE/H/734/01/DC

ESPEN Congress Cannes Education and Clinical Practice Programme

Anemia 1: Fourth year Medical Students/ Feb/22/ Abdallah Awidi Abbadi.MD.FRCP.FRCPath Professor

Objectives. Current WHO Definition of Anemia. Implication for Clinical Practice 10/8/18. Prevalence of Iron Deficiency in Women Undergoing Surgery

Prof. Dr. med. Christian Breymann Zurich, Switzerland 15 May 2017

GP refresher course Anaemia. Peter MacCallum Consultant Haematologist Barts Health NHS Trust London January 2018

State of the iron: How to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease

ANEMIA IN THE PRE-SURGICAL PATIENT

INFLAMMATORY BOWEL DISEASE

Nutritional anaemia. Dr J Potgieter Dept of Haematology NHLS - TAD

Hepcidin is a key mediator of anemia of inflammation in Crohn's disease

Iron deficiency is the most common single cause

See Important Reminder at the end of this policy for important regulatory and legal information.

Assessing Iron Deficiency in Adults. Chris Theberge. Iron (Fe) deficiency remains as one of the major global public health problems for

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor

Clinical Policy: Iron Sucrose (Venofer) Reference Number: CP.PHAR.167

Tariq Iqbal Jürgen Stein Naveen Sharma Stefanie Kulnigg-Dabsch Senthil Vel Christoph Gasche

Anaemia in Pregnancy

Clinical Study The Effect of Intravenous Iron Treatment on Quality of Life in Inflammatory Bowel Disease Patients with Nonanemic Iron Deficiency

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia

In-House. Solution for Injection A dark brown coloured, slightly viscous solution filled in ampoule.

Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review

NEW RCPCH REFERENCE RANGES-

Incidence rate of anemia in inflammatory bowel diseases

Iron deficiency in heart failure

Venofer 20 mg iron / ml, solution for injection or concentrate for solution for infusion.

ANEMIA IN THE PRE-SURGICAL PATIENT

Dr. Hasan Fahmawi, MRCP (London), FRCP(Edin) Consultant Physician ANAEMIA

Lisa B. Weissmann, MD

Iron Therapy. Product Monograph. Version 1.4. low Mw iron dextran

Injectable Iron Products

To help protect your privacy, PowerPoint prevented this external picture from being automatically downloaded. To download and display this picture,

Shân Edwards Clinical Pharmacist Royal Devon & Exeter Hospital November 2012

Cows Milk or follow on Formula. Hilton 26/10/2014

The use of Parenteral Iron in Pregnancy

ESM Table 2 Data extraction form and key data from included studies

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014

Guidelines on Anaemia Management in Patients with Chronic Kidney Disease (CKD)

Microcytic Hypochromic Anemia An Approach to Diagnosis

FBC interpretation. Dr. Gergely Varga

Maintenance intravenous iron therapy in pediatric hemodialysis patients Morgan H E, Gautam M, Geary D F

, :, ,

PDF of Trial CTRI Website URL -

Dr Dominic Fleischer

Transcription:

Oxford Inflammatory Bowel Disease & Hepatology MasterClass Managing Anaemia in IBD Dr Alex Kent Senior Research Fellow

Disclosures

WHO Classification of Anaemia Normal haemoglobin and haematocrit levels Population group Haemoglobin Haematocrit g/dl Mmol/L % Children 6 mo 5 years 11.0 6.83 33 Children 5-11 years 11.5 7.13 34 Children 12-14 years 12.0 7.45 36 Non-pregnant women 12.0 7.45 36 Pregnant women 11.0 6.83 33 Men 13.0 8.07 39 WHO/UNICEF/UNU. Iron deficiency anemia: Assessment, prevention and control. Report of a joint WHO/UNICEF/UNU consultation. Geneva; World Health Organisation, 1998

Impact of anaemia asymptomatic Reduced quality of life: equalling cancer 1 Higher disease activity 2 : reduced hct & general well-being Chronic fatigue Impaired cognitive performance 3 Reduced mood Increased incidence of and morbidity from infectious diseases 4 Thyroid dysfunction & impaired thermoregulation 5 Pregnancy: preterm delivery, low birth weight, reduced neonatal health 6 References: 1. Leitgeb C et al. Cancer 1994: 2535-2542 2. Schreiber S et al. NEJM 1996:619-623 3. Beard JL et al. Am J Clin Nut 2007:778-787 4. Basta SS et al. Am J Clin Nut1979: 916-925 5. Dillman E et al. Am J Physio 1980:R377-381 6. Allen LH et al. Am J Clin Nut 2000:1280S-4S

Causes of anaemia in IBD Iron Deficiency Anaemia Anaemia of Chronic Disease Vitamin B 12 / folate deficiency 1 Haemolysis 2 Myelodysplastic syndrome 3 Drug-induced: Thiopurine 4 Sulfasalazine 5 Methotrexate 6 References: 1. Fernandez-Banares F et al. Am. J. Gastroenterol 1989;84(7):744-8. 2. Bell DW et al. South Med. J., 1981;74(3):359-61. 3. Wang, Z et al. Dig. Dis. Sci.2008;53(7):1929-32. 4. Corominas H et al. Med. Clin. (Barc.) 2000;115(8):299-301 5. Dunn AM et al. Lancet 1981;2(8258):1288. 6. Bellaiche G et al. Gastroenterol. Clin. Biol. 1999;23(10):1102-3.

Screening bloods Full blood count MCV Serum ferritin Transferrin saturation Haptoglobin Lactate dehydrogenase Creatinine Reticulocyte count CRP Vitamin B 12 Folate

Distribution of iron in adults 3-4 kg iron in human body

Iron absorption Maximum absorption: 20mg per day

Iron deficiency anaemia Prevalence 45% 1 Causes: Blood loss 1 ml blood = 0.5 mg iron daily losses >4ml = iron deficiency Poor nutritional uptake 2 Impaired iron absorption 3 SB Crohn s disease References: 1. Gisbert JP et al. Am J Gastro 2008:1299-1307 2. Lomer MC et al. Br J Nutr 2004:141-148 3. Semrin G et al. Inflamm Bowel Dis 2006:1101-1106

Iron deficiency anaemia: Treatment Aims: Hb rise of 2g/dL in 4 weeks Normalisation of Hb, ferritin and TF saturation Greatest improvement in QoL at 11 12 g/dl 1 Options: Oral iron Parenteral iron References: 1. Crawford J et al. Cancer 2000:888-895.

Oral iron Iron requirements (Body weight (kg) x (target Hb* (g/dl) actual Hb) x 2.4) + mg iron for stores # *Target Hb: for body weight below 35 kg = 13 g/dl; for body weight 35 kg and above = 15 g/dl #Depot iron: for body weight below 35 kg = 15 mg/kg body weight; for body weight 35 kg and above = 500 mg

Oral iron (cont) Maximum absorption of elemental iron is 20mg per day Elemental iron content of iron salts Iron salt Dose Iron content (%) Iron content Cost Ferrous sulphate 200mg 30 65mg 1.07 (28) Ferrous fumarate 200mg 33 65mg 2.30 (84) Ferrous gluconate 300mg 11.6 35mg 1.93 (28) Concerns: Side effects / intolerance 2 : 21-52% Toxic reactive oxygen species Slow response References: 1. Micromedex Healthcare Series, 2007. Thomson Healthcare Inc 2. 1. Kerr DN et al. Lancet 1958;489-492

Parenteral iron Iron gluconate Less stable, leading to labile iron release higher risk of A/E Maximum dose 125mg Iron dextran (low molecular weight) Dextran-related anaphylaxis; test dose required Long infusion time; large doses Long time interval before bioavailibility Iron sucrose (venofer) 95% of iron utilised within 2-4 weeks Maximum dose 600mg/week in 200mg infusions Iron carboxymaltose (ferrinject) Rapidly infused (1000mg in 15 mins); no test dose Iron utilised within 6-9 days so lower risk of A/E

Summary of parenteral iron preparations Maximum single dose LMW iron dextran Cosmofer Iron sucrose Venofer Iron carboxymaltose Ferrinject 20mg/kg 200mg 1000mg (20mg/kg) Rapid infusion No Yes (bolus) Yes Yes Test dose? Yes Initial No No Iron concentration Iron isomaltose Monofer 20mg/kg Blood 50 mg/ml 20 mg/ml 50 mg/ml 100 mg/ml 200mg per unit Vial volumes 2 & 10 5 2 & 10 1, 5 & 10 Cost 7.97 / 39.85 9.35 19.10 / 95.50 16.95 / 84.75 / 169.50

Parenteral iron (cont.) Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. Gasche C et al. Inflamm Bowel Dis. 2007 Dec;13(12):1545-53. Statement 4A: The preferred route of iron supplementation in IBD is intravenous, even though many patients will respond to oral iron. Intravenous iron is more effective, better tolerated, and improves the quality of life to a greater extent than oral iron supplements. (Grade A)

Indications for intravenous iron Haemoglobin <10g/dL Intolerance to oral iron Poor response to oral iron Moderate-severe disease activity Concomitant treatment with erythropoietic agent Patient preference

Anaemia of Chronic Disease Causes: Functional iron deficiency 1 Up-regulation of ferritin Reduced transferrin Inhibition of erythropoiesis 2 IL-1 & TNF-α produce toxic radicals damage erythropoietin-producing cells Inhibition of differentiation/proliferation of erythroid precursors 3 Interferon-α, -β, -γ, TNF-α and IL-1 Uptake and retention of iron in the reticulo-endothelial system 4 Interferon-γ, TNF-α and IL-6 Hepcidin References: 1. Macdougall IC et al. BMJ 1992:225-226 2. Faquin WC et al. Blood 1992:1987-1994 3. Theurl I et al. Blood 2006:4142-4148 4. Weiss G et al. NEJM 2005:1011-1023

Iron absorption Maximum absorption: 20mg per day

Identifying the cause of anaemia Ferritin (μg/l) Active No inflammation inflammation Transferrin saturation (%) MCV MCH str IDA <100 <30 <16 ACD >100 >100 <16 Normal Normal Normal or

Take home message Ask carefully for symptoms of anaemia Anaemia should raise concerns about disease activity Oral iron only in mild anaemia and inactive disease Do not overtreat with oral supplements Early treatment Intravenous iron is preferable